Mapping the Steroid Response to Major Trauma From Injury to Recovery : A Prospective Cohort Study by Foster, MA et al.
doi:10.1210/clinem/dgz302 J Clin Endocrinol Metab, March 2020, 105(3):1–13  https://academic.oup.com/jcem  1
*Equal senior authors.
ISSN Print 0021-972X ISSN Online 1945-7197
Printed in USA
Received 27 June 2019. Accepted 31 January 2020.
First Published Online 26 February 2020.
Corrected and Typeset 26 February 2020. 
C L I N I C A L  R E S E A R C H  A R T I C L E
Mapping the Steroid Response to Major Trauma From 
Injury to Recovery: A Prospective Cohort Study
Mark A. Foster,1,2 Angela E. Taylor,3,4 Neil E. Hill,5 Conor Bentley,1,2 Jon Bishop,1,2 
Lorna C. Gilligan,3,4 Fozia Shaheen,3,4 Julian F. Bion,6 Joanne L. Fallowfield,7  
David R. Woods,2,8 Irina Bancos,9 Mark M. Midwinter,10 Janet M. Lord,1,11,12,* and 
Wiebke Arlt3,4,12,*
1NIHR-Surgical Reconstruction and Microbiology Research Centre, Queen Elizabeth Hospital Birmingham, 
University Hospitals Birmingham NHS Foundation Trust, Birmingham, B15 2WB, UK; 2Royal Centre for 
Defence Medicine, Queen Elizabeth Hospital Birmingham, B15 2TH, UK; 3Institute of Metabolism and 
Systems Research, University of Birmingham, Birmingham, B15 2TT, UK; 4Centre for Endocrinology, 
Diabetes and Metabolism, Birmingham Health Partners, University of Birmingham, Birmingham, B15 2TH, 
UK; 5Section of Investigative Medicine, Imperial College London, W12 0NN, UK; 6Intensive Care Medicine, 
Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, B15 2TH, 
UK; 7Institute of Naval Medicine, Alverstoke, Hampshire, PO12 2DL, UK; 8Leeds Beckett University, Leeds, 
UK; 9Division of Endocrinology, Metabolism and Nutrition, Department of Internal Medicine, Mayo Clinic, 
Rochester, Minnesota; 10School of Biomedical Sciences, University of Queensland, Brisbane, 4072a, Australia; 
11MRC-ARUK Centre for Musculoskeletal Ageing Research, Institute of Inflammation and Ageing, University 
of Birmingham, Birmingham, B15 2TT, UK; and 12NIHR Birmingham Biomedical Research Centre, University 
Hospitals Birmingham NHS Foundation Trust and University of Birmingham, Birmingham, B15 2GW, UK
ORCiD numbers: 0000-0003-1951-9155 (M. A. Foster); 0000-0001-9332-2524 (I. Bancos).
Context: Survival rates after severe injury are improving, but complication rates and outcomes 
are variable.
Objective: This cohort study addressed the lack of longitudinal data on the steroid response to 
major trauma and during recovery.
Design: We undertook a prospective, observational cohort study from time of injury to 
6 months postinjury at a major UK trauma centre and a military rehabilitation unit, studying 
patients within 24 hours of major trauma (estimated New Injury Severity Score (NISS) > 15).
Main outcome measures: We measured adrenal and gonadal steroids in serum and 24-hour 
urine by mass spectrometry, assessed muscle loss by ultrasound and nitrogen excretion, and 
recorded clinical outcomes (ventilator days, length of hospital stay, opioid use, incidence of 
organ dysfunction, and sepsis); results were analyzed by generalized mixed-effect linear models.
Findings: We screened 996 multiple injured adults, approached 106, and recruited 95 eligible 
patients; 87 survived. We analyzed all male survivors <50 years not treated with steroids (N = 60; 
median age 27 [interquartile range 24–31] years; median NISS 34 [29–44]). Urinary nitrogen 
excretion and muscle loss peaked after 1 and 6 weeks, respectively. Serum testosterone, 
dehydroepiandrosterone, and dehydroepiandrosterone sulfate decreased immediately after 
trauma and took 2, 4, and more than 6 months, respectively, to recover; opioid treatment 
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delayed dehydroepiandrosterone recovery in a dose-dependent fashion. Androgens and 
precursors correlated with SOFA score and probability of sepsis.
Conclusion: The catabolic response to severe injury was accompanied by acute and sustained 
androgen suppression. Whether androgen supplementation improves health outcomes after 
major trauma requires further investigation. (J Clin Endocrinol Metab 105: 1–13, 2020)
Key Words:  major trauma, systemic inflammatory response syndrome, stress response, steroids, 
DHEA, testosterone
Over 5 million people worldwide die each year from serious injury (1), with almost 25% caused by road 
traffic collisions (RTC) (2). In England alone, there are 
5400 trauma deaths and 20 000 severe injuries treated 
by the National Health Service annually (3). Since 2012, 
the establishment of 22 trauma centers in England has 
been accompanied by a 19% improvement in survival 
odds following injury (4). During this time, the United 
Kingdom also received severely injured military trauma 
patients from the conflict in Afghanistan (5).
Improvements in short-term outcomes have been 
achieved through early resuscitation and acute care (6), 
often informed by approaches pioneered on the battle-
field. However, improvement in survival is often offset 
during the weeks following acute major trauma by the 
systemic inflammatory response syndrome (SIRS), which 
is associated with increased risks of infection, multiorgan 
dysfunction or failure (MOD/MOF), and death (7, 8). 
Simultaneously, the hypothalamic-pituitary-adrenal axis 
(HPA) is thought to drive a hypermetabolic and overtly 
catabolic response. Importantly, in this profound cata-
bolic state, patients lose valuable lean muscle and suffer 
from increased rates of infection and poor wound healing. 
Moreover, the dynamic nature of this response, especially 
beyond the first few days following injury and during re-
covery remains poorly described and understood, limiting 
the evidence base for novel therapeutic interventions. Burn 
injury also produces an extreme inflammatory and cata-
bolic response after injury, previously targeted by anabolic 
steroid analogues (9) and beta-blockade (10). The dynamic 
changes in endogenous glucocorticoids and their influence 
on adrenal steroid metabolism after severe injury are not 
well characterized. We know that proinflammatory cyto-
kines activate the enzyme 11β-hydroxysteroid dehydro-
genase type (11β-HSD1) responsible for tissue-specific 
activation of glucocorticoids through the conversion of 
inactive cortisone to active cortisol (11). However, only 
scarce data exist on what happens to early sex steroids 
and their precursors during this catabolic state.
To address these gaps in knowledge, we have under-
taken a detailed prospective study of the endocrine and 
metabolic response to severe injury in military and civilian 
populations, recruiting patients within 24 hours of major 
trauma and following up for the 6 months post-trauma. 
This was undertaken to identify predictive biomarkers 
and therapeutic targets as well as to explore the optimal 
timing for therapeutic interventions that could promote 
better recovery after severe traumatic injury.
Materials and Methods
Study design and protocol
This prospective cohort study was conducted in the Royal 
Centre for Defense Medicine and the Queen Elizabeth Hospital 
Birmingham, a major UK trauma center and the primary re-
ceiving facility for UK military personnel injured abroad. 
Military and civilian trauma patients with an estimated New 
Injury Severity Score (NISS) >15 were recruited (12). The NISS 
was used to ensure those with significant extremity trauma but 
lower injury severity score were included (13). Patients with 
significant head injury or preinjury neoplastic conditions were 
not eligible. None of the patients received etomidate during 
their treatment. Informed consent was obtained from per-
sonal consultees until recovering capacity. The protocol was 
approved by the NRES Committee South West – Frenchay 11/
SW/0177 and MOD REC 116/Gen/10.
A daily patient review allowed the injured to be clinically 
phenotyped. Bespoke study management software (Clinical 
RESearch Tool – CREST) tracked the patient and their clinical 
data were entered prospectively and used to calculate an Acute 
Physiology and Chronic Health Evaluation II (APACHE II), 
Sequential Organ Failure Assessment (SOFA), and Simplified 
Acute Physiology Score (SAPS) (14, 15). Sepsis was defined 
using Bone’s criteria of an infection associated with SIRS (16), 
current at the time of the study.
Details of opioid administration were collected from the elec-
tronic health record and prescribing system (PICS) (17) on each 
of the study patients. The total amount of opioid given during 
their hospital stay was appropriately weighted and totaled with 
equivalence to an oral dose of 10 mg morphine, adjusting for 
potency, delivery method, and opioid preparation (18).
Blood and urine samples were collected within 24 hours 
of acute injury and at 3, 5, 10, 14, 21, 28 days and 2, 3, 4, 
and 6  months during recovery post-trauma. Blood sampling 
occurred between 7:30 am and 9:00 am; serum was then sep-
arated and frozen at -80oC for batched analysis. We separately 
collected morning blood samples from 37 healthy age- and sex-
matched controls, to provide a comparator for the steroid data.
Assessment of protein catabolism
As a surrogate marker for muscle mass, we undertook lon-
gitudinal measurements of muscle thickness by a well-validated 
method using portable ultrasound as described by Campbell et al 
(19, 20). Ultrasound measurements were taken from 4 different 
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muscle sites (biceps brachii, radial forearm, rectus femoris, and 
rectus abdominis) at weekly intervals while in hospital and at 3, 
4, 5, and 6 months following discharge. All ultrasound assess-
ments were performed by 2 trained operators. Measurements 
were performed 3 times at each muscle site and the mean of the 
3 measurements was recorded. The dominant arm was favoured 
for ultrasound assessment of muscle mass unless it was missing 
or unable to be measured where wounds were extensive. This 
noninvasive method was chosen over others such as creatine (me-
thyl‐d3) dilution (D3‐creatine) (21) due to the strict dietary re-
quirements for methy-d3 estimation, which was not practical in 
the context of major trauma. Similarly, we did not undertake MRI 
measurement of muscle mass due to the risk associated with re-
peated transport of critically ill patients to scanning facilities (22).
Urinary urea excretion was measured and used to estimate 
total urinary nitrogen (TUN) excretion as described by Milner 
et al (23) (estimated nitrogen excretion: urinary urea excretion 
(mmol/l) × 0.028 × 1.25 = total urinary nitrogen excretion (g/l)].
Steroid analysis
Serum concentrations of adrenal and gonadal steroids were 
measured using liquid chromatography-tandem mass spectrom-
etry (LC-MS/MS) analysis, employing a validated multisteroid 
profiling method (24). In brief, serum steroids were extracted 
via liquid/liquid tert-butyl-methyl-ether (MTBE), evaporated, 
reconstituted, and analyzed by LC-MS/MS for cortisol and 
cortisone. Serum androgens and androgen precursors (DHEA, 
androstenedione, testosterone) were measured following oxime 
derivatization (25, 26). Serum DHEA sulfate (DHEAS) was 
measured following protein precipitation (27, 28). Steroid metab-
olite excretion analysis in 24-hour urine samples was carried out 
by gas chromatography-mass spectrometry (GC-MS) in selected-
ion-monitoring (SIM) mode, as previously described (29).
Serum concentrations of sex hormone-binding globulin 
(SHBG) and luteinizing hormone (LH) were analyzed on the 
Roche Modular System (Roche Diagnostics, Lewes, UK) by 
2-site sandwich immunoassay using electrochemiluminesence 
technology.
Statistical analysis
The raw data were evaluated by analysis of variance 
(ANOVA). In addition, paired and unpaired Student’s t-test, 
Chi-Square analysis, and Mann-Whitney tests were used 
where appropriate.
Generalized linear mixed-effects models (30) were used 
to examine the change in variables over time. Patients were 
included in models as random effects to account for repeat 
measures over time on the same individuals. Time was mod-
elled using restricted cubic splines (31) to allow for flexible 
relationships (32). Severity scores were modeled as Poisson 
distributions due to their skewness and non-negative ranges. 
Plots of predicted average fixed effects with 95% confi-
dence intervals were produced for the first 4 weeks and first 
6 months postinjury as required. Analyses were conducted in 
R using libraries lme4, effects, rms, and ggplot2.
Results
Patient recruitment and clinical characteristics 
of the final study cohort
We screened 996 multiply injured adults. The ma-
jority of the 889 excluded patients had a NISS  ≤  15, 
others had a significant head injury as their major in-
jury component, and 2 were excluded due to a preinjury 
diagnosis of cancer. Of the 102 patients recruited into 
the study, 2 withdrew, and reassessment in 5 revealed an 
actual NISS ≤ 15, leaving a study cohort of 95 patients 
(Fig. 1A).
Excluding 8 fatalities and 7 patients who had re-
ceived steroid therapy, 80 survivors completed sample 
collection over 6 months. To minimize confounders, we 
excluded the small groups of women (n = 9) and age-
advanced men (n = 11), leaving our final study cohort of 
60 men <50 years of age (Fig. 1B).
A summary of the cohort characteristics is shown in 
Fig.  2. Median age was 27 (interquartile range [IQR] 
24–31) years, median NISS was 34 (IQR 29–44), and 
patient day-1 (  =  day of major trauma) APACHE II 
score was 21 (IQR 14–25). Patients remained ventilated 
on the intensive care unit (ICU) for a median of 9 (IQR 
5–16) days. Median length of hospital stay was 36 (IQR 
19–56) days. Improvised explosive device (IED) (n = 33; 
55%) and RTC (n = 11; 18%) were the most common 
causes of injury. Twenty-five (42%) patients had at least 
1 septic episode and most occurred in the second week 
(Fig. 2C).
Glucocorticoid biosynthesis and metabolism after 
major trauma
Serum cortisol concentrations increased slightly 
after injury, peaking at 408 (IQR 249–511) nmol/L 
at 2 weeks (Fig.  3A) (33). However, concentrations 
remained within the wide range observed in healthy 
controls. Serum concentrations of the inactive gluco-
corticoid metabolite cortisone were lower than normal 
after injury, and increased slowly over time, but this 
trend was not significant (P  =  0.08) (Fig.  3B) (33). 
The serum cortisol-to-cortisone ratio, a marker of sys-
temic 11β-HSD activities (Fig. 3C), peaked at 2 weeks 
postinjury and returned to normal at around 8 weeks. 
Consistent with these findings, urinary steroid metab-
olite excretion analysis revealed an increase in gluco-
corticoid metabolite excretion in weeks 2, 4, and 
8 after major trauma, alongside changes in steroid 
metabolite ratios indicative of increased systemic 
11β-HSD1 and decreased 11β-HSD2 activities, as as-
sessed by (5α-tetrahydrocortisol + tetrahydrocortisol)/
tetrahydrocortisone and cortisol-to-cortisone ratio, re-
spectively (33).
Androgen biosynthesis and activation after 
major trauma
Serum concentrations of the adrenal androgen pre-
cursor dehydroepiandrosterone (DHEA) were very low 
after injury (P  < 0.0001, compared with healthy con-
trols) but recovered to the normal range by 3 months 
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postinjury (Fig.  3D) (33). In contrast, its sulfate ester, 
DHEAS, demonstrated sustained suppression; median 
serum DHEAS concentrations did not recover to values 
within the healthy reference range, even at the end of 
the 6-month study period (Fig. 3E). Consequently, the 
serum DHEA-to-DHEAS ratio (Fig.  3F) increased by 
Figure 2. Patient characteristics of the analysis cohort. A, Demographics. B, Mechanism of injury. C, The distribution of septic episodes for 60 male 
survivors from severe injury (NISS > 15) under 50 years of age.
A BTrauma Assessed for 
Eligibility
n=995
(355 military, 640 civilians)
Approached 
n=106
(54 military, 52 civilians)
Did Not meet
inclusion criteria
n= 889
Recruited 
n=102
(52 military, 50 civilians)
Refused
n=4
Study population
n=100
(51 military, 49 civilians)
Withdrawn
n=2
NISS>15
n=95
(49 military, 46 civilians)
Actual NISS≤15
n=5
All patients recruited
n=95 (85m, 10f)
NISS = 34 (27-43)
All Survivors
n=87(78m, 9f)
NISS = 34 (27-43)
Fatalities
(n=8)
NISS = 41 (31-57)
Male Survivors
n=78
NISS = 34 (29-45)
Female Survivors
(n=9) 
NISS 27 (22-27)
Male Survivors
no steroids
n=71
NISS = 34 (27-43)
Male Survivors
given steroids
(n=7)
NISS 57 (41-57)   
Male Survivors
no steroids <50yrs
n=60
NISS 34 (29-44)
Male Survivors ≥
50yrs
no steroids (n=11)
NISS = 27 (22-34) 
Survived
Males
No steroids
<50 years old
Figure 1. Consort diagram. A, recruitment process. B, subgroup selection for analysis for 60 male survivors of severe injury (NISS > 15) under 
50 years of age who had not been given exogenous steroids were analyzed.
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week 2 compared with controls and failed to return to 
normal during the 6-month study period. The serum 
cortisol-to-DHEAS ratio (Fig. 3G) increased postinjury, 
peaking at 2 weeks, followed by a gradual decrease, but 
without returning to normal by the end of the 6-month 
study period.
Serum concentrations of the androgen precursor 
androstenedione (Fig.  3H) were below the refer-
ence range immediately after injury, recovering to the 
midreference range at 2 weeks postinjury. Thus, serum 
androstenedione concentrations recovered much faster 
than DHEA, suggestive of rapid downstream activation 
of DHEA to androstenedione.
Serum testosterone (Fig.  3I) (33) was very low fol-
lowing injury, starting to increase after 2 weeks, and re-
covering to the healthy sex- and age-matched reference 
range approximately 8 weeks after injury. This was mir-
rored by acute suppression of serum LH immediately 
after injury, followed by recovery to the normal range 
approximately 2 weeks after injury (33). Serum sex 
hormone-binding globulin (SHBG) (33) concentrations 
were subnormal immediately postinjury, but quickly 
returned to the healthy reference range between injury 
and day 7.
Consistent with the observed decrease in circulating 
androgens, 24-hour urinary steroid metabolite excretion 
Figure 3. Serum steroids in 60 male survivors of severe injury (NISS > 15) under 50 years of age. Serum concentrations shown include A, 
cortisol; B, cortisone; C, the cortisol-to-cortisone ratio; D, DHEA; E, DHEAS; F, the DHEA-to-DHEAS ratio; G, the cortisol-to-DHEAS ratio; H, 
androstenedione; and I, testosterone. Data are represented after modeling of the raw data (33) using a nonlinear mixed effects model that 
accounts for unbalanced repeated measures using a 4-knot cubic spline. Modeled data are shown as means and 95% confidence intervals.
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analysis revealed a steep decrease in the major an-
drogen metabolites androsterone and etiocholanolone 
at 2, 4, and 8 weeks (33). Similarly, urinary DHEA ex-
cretion, representing the sum of unconjugated DHEA 
and DHEA sulfate, sharply decreased to very low con-
centrations at 2, 4, and 8 weeks, with a transient in-
crease in 16α-hydroxylation of DHEA at 2 weeks 
(33), possibly linked to the systemic decrease in DHEA 
sulfation (Fig. 3D–F). The overall decrease in androgen 
production was paralleled by a profound decrease in 
systemic 5α-reductase activity (33), and hence in an-
drogen activation, as 5α-reductase is responsible for 
converting testosterone to the most potent androgen 
5α-dihydrotestosterone.
Protein catabolism after major trauma
The 24-hour TUN excretion increased immediately 
after trauma, peaking at 25.0 ± 16.1 g/day at the end of 
the first week, returning to below 15.0 g/day by week 
4. The mean maximum rate of nitrogen excretion was 
33.0 ± 21.3 g/day (Fig. 4A). The normalization of TUN 
excretion coincided with the gradual recovery of ad-
renal and gonadal androgen production (Fig.  4B and 
4C).
The biceps brachii muscle was the most reliable site 
for ultrasound measurement of muscle thickness; dress-
ings, amputations, and other wounds hampered the 
measurements of the other muscle areas. Changes in 
biceps brachii muscle thickness followed a U-shaped 
curve after injury, reaching a nadir at 6 weeks (day-1 
after trauma compared with week 6, P  = 0.001). The 
mean muscle loss was 22.7 ± 12.5% (Fig. 4D). Similar 
to TUN, muscle thickness recovered alongside gradually 
increasing adrenal and gonadal androgen production 
(Fig. 4E and 4F).
Clinical course of post-traumatic recovery and 
serum androgen dynamics
The relationship between adrenal and gonadal 
androgens and the Sequential Organ Failure Score 
(SOFA) and probability of sepsis are illustrated 
in Fig.  5. During the first 4 weeks, serum DHEA, 
DHEAS, and testosterone all correlated with the clin-
ical SOFA score (autocorrelation factor [ACF] = 0.85, 
0.90, and -0.79, respectively). The serum concen-
trations of all 3 steroids also showed strong asso-
ciations with the probability of sepsis (R  =  -0.85, 
0.85, and -0.97 for serum DHEA, DHEAS, and 
Figure 4. The relationship between A, urinary nitrogen excretion or B, biceps muscle thickness with (B and D) DHEA and (C and F) testosterone, 
over time for young (<50), severely injured (NISS > 15) males who had survived and not been given anabolic steroids. Muscle thickness data was 
modeled using a mixed effects technique; modeling time as a 6- and 7-knot restricted cubic spline respectively provided the best fit. Data are 
means and 95% confidence intervals for model-based predicted fixed effects of time are shown.
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testosterone, respectively). The SOFA score and 
probability of sepsis also correlated strongly with 
the DHEA:DHEAS ratio (ACF = -0.94 and -0.96, re-
spectively) and with the serum cortisol-to-DHEAS 
ratio, negatively for the SOFA score but positively 
for probability of sepsis (ACF = -0.81 and 0.89, re-
spectively) (33).
Opioid administration and endocrine recovery
To examine whether opioid administration affected 
endocrine recovery, we modeled the impact of the total 
cumulative in-patient opioid dose on circulating steroid 
concentrations during recovery from major trauma. For 
this purpose, we categorised patients according to cu-
mulative opioid dose. Modeling took into account the 
differences in injury severity score, length-of-stay (LOS), 
ICU LOS, and SOFA score.
The adjusted modeling revealed a dose-dependent 
impact of opioid treatment, with a higher initial peak 
of serum cortisol and the cortisol/cortisone ratio in 
those on higher doses (≥3000 mg), while those on lower 
doses had initially lower serum cortisol concentrations 
but showed better recovery of cortisol and cortisol/cor-
tisone 2 months into the recovery period, with broad 
interindividual variability in those with high cumulative 
opioid doses (Fig. 6).
Opioid administration showed a pronounced, dose-
dependent effect on adrenal and gonadal androgen pro-
duction, with significantly delayed recovery of serum 
DHEA and DHEAS in patients on higher opioid doses 
Figure 5. Sequential Organ Failure Assessment (SOFA) score and probability of sepsis in relation to endocrine response. The SOFA and sepsis are 
related serum concentrations of DHEA (A and B), DHEAS (C and D), and testosterone (E and F). Data were modeled using a nonlinear mixed effects 
model that accounts for unbalanced repeated measures using a 4-knot cubic spline. Modeled data are reported as means and 95% confidence 
intervals.
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(P = 0.029, P = <0.001, respectively; Fig. 7). By contrast, 
serum testosterone concentrations, which were ini-
tially equally suppressed in all cumulative dose groups, 
showed a much faster recovery in individuals who re-
ceived higher (≥3000 mg) total cumulative opioid doses. 
However, these confidence intervals were large for these 
model estimates (Fig. 7).
Discussion
In this study, we have characterized the response of ad-
renal and gonadal steroids and catabolic metabolism to 
severe injury, describing the related dynamic changes for 
6 months postinjury. Modeling the data has allowed us 
to provide a detailed description of the transition from 
catabolism to anabolism during recovery from severe 
injury, including investigating the impact of cumulative 
in-patient opioid dose. Our data are the first to provide 
detailed adrenal and gonadal steroids beyond the first 
days after trauma in a large cohort of young patients, 
with all patients recruited prospectively and steroid ana-
lysis carried out by tandem mass spectrometry.
As summarized in a recent meta-analysis (34), pre-
vious data on serum cortisol after injury are limited 
to small cohorts derived from elective surgery, rarely 
followed-up for more than 2 days. In our study, serum 
cortisol quickly returned to normal following slight ini-
tial increases after acute trauma. In contrast, serum cor-
tisone remained low for 3 months postinjury. Our study 
revealed an initial phase of minor glucocorticoid activa-
tion with a transient increase in the serum cortisol-to-
cortisone ratio, with changes in urinary glucocorticoid 
metabolites indicative of increased 11β-HSD1 activity. 
The cortisol-activating enzyme 11β-HSD1 is the major 
enzyme converting inactive cortisone to cortisol and has 
been shown to be upregulated systemically and locally 
Figure 6. Impact of total inpatient opioid dose on circulating glucocorticoids after major trauma. Serum concentrations are scaled for cortisol, 
cortisone, the cortisol-to-cortisone ratio, and the cortisol-to-DHEAS ratio. Data are represented after modeling of the raw data using a nonlinear 
mixed effects model that accounts for unbalanced repeated measures using a 4-knot cubic spline. Modeled data are shown as means and 95% 
confidence intervals.
8  Foster et al  The Steroid Response to Major Trauma J Clin Endocrinol Metab, March 2020, 105(3):1–13
Copyedited by: OUP
D
ow
nloaded from
 https://academ
ic.oup.com
/jcem
/article-abstract/105/3/dgz302/5758226 by guest on 28 February 2020
in response to inflammation, thereby dampening the in-
flammatory response (35, 36). Skeletal muscle expresses 
11β-HSD1 (37). Previous studies reported increased 
11β-HSD1 activity in an animal model of trauma 
haemorrhage (38) and improved wound healing in 
mice treated with 11β-HSD1 inhibitors (39). However, 
human data after trauma are lacking. There is substan-
tial evidence indicating a reduced cortisol clearance in 
critical illness, due to decreased cortisol inactivation in 
liver and kidney (40); this mechanism could also be re-
sponsible for the slight changes in cortisol and cortisone 
we observed. This was corroborated by the observed re-
duction in the urinary cortisol-to-cortisone ratio, which 
is reflective of 11β-HSD2 activity.
Interestingly, patients on higher opioid doses showed 
a higher early peak in cortisol production after trauma, 
followed by persistently lower circulating cortisol during 
the recovery period, as compared with patients on lower 
opioid doses. Previous reports have described suppres-
sive effects of opioids on the HPA axis, though studies 
in smaller mammals have indicated an acute stimulatory 
effect of opioid administration on serum cortisol con-
centrations (41, 42).
We observed a pronounced and sustained loss of 
adrenal and gonadal androgen synthesis within the 
first 24 hours following acute major trauma. The re-
covery of circulating DHEA and testosterone concen-
trations took 2 and 4 months postinjury, respectively, 
and DHEAS remained pathologically suppressed at 
the end of the 6-month follow-up period. In a mouse 
model of acute inflammation, sustained suppres-
sion of the expression of the DHEA sulfotransferase 
SULT2A1 and its sulfate donor enzyme, PAPSS2, have 
been described (43). We reviewed 23 previous studies 
that measured serum DHEA and DHEAS in critically 
ill patients (33, 44), but most studies followed patients 
Figure 7. Impact of total inpatient opioid dose on serum androgen and androgen precursors after major trauma. Serum concentrations are scaled 
for DHEA, DHEAS, the DHEA/ DHEAS ratio, and testosterone. Data are represented after modelling of the raw data using a non-linear mixed effects 
model that accounts for unbalanced repeated measures using a 4-knot cubic spline. Modelled data are shown as means and 95% confidence 
intervals.
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for only a few days and relatively few patients suffered 
from acute trauma. One previous study measured both 
serum DHEA and DHEAS in 181 patients with septic 
shock and 31 patients with acute hip fracture (45). 
Serum DHEAS was decreased in both groups, while 
DHEA was increased in sepsis but decreased after 
trauma. This suggested an inflammation-mediated 
downregulation of DHEA sulfation after trauma, re-
sulting in a dissociation of serum DHEA and DHEAS. 
In our study, this was also observed, as indicated by a 
sustained increase in the serum DHEA/DHEAS ratio 
and persistently low serum DHEAS concentrations.
A number of previous studies have described an asso-
ciation of infection and mortality with low circulating 
DHEAS concentrations and a raised serum cortisol-to-
DHEAS ratio in patients with trauma (46–49). In vitro 
studies have demonstrated that cortisol decreases neu-
trophil superoxide production, which is counteracted by 
coincubation with DHEAS (46). Furthermore, we have 
previously shown that DHEAS, but not DHEA, directly 
enhances neutrophil superoxide generation, a key mech-
anism of human bactericidal function via activation of 
protein kinase C-β, independent of androgen receptor 
signalling (50). In the present study, carried out in se-
verely injured men younger than 50 years of age, we ob-
served suppression of both serum DHEA and DHEAS 
postinjury, indicating that the loss of adrenal androgen 
synthesis is a trauma-related event. Importantly, we 
showed for the first time that this decrease in circulating 
adrenal androgen precursors is sustained for several 
months, and that DHEAS remains low even 6 months 
postinjury.
Alongside the decrease in adrenal androgen syn-
thesis, we observed a near complete loss of gonadal 
testosterone production and pituitary LH secretion im-
mediately after trauma. Both the gradual recovery of 
adrenal and gonadal androgen production paralleled 
the decrease in catabolism, as assessed by urinary ni-
trogen excretion and biceps muscle thickness. The sup-
pression of the hypothalamus-pituitary-gonadal (HPG) 
axis after severe injury shown in our study is supported 
by the literature (51–54). Our prospective, longitudinal 
data demonstrate that suppression of the HPG axis is 
of shorter duration than that of the HPA axis. In trau-
matic brain injury studies, a significant proportion of 
patients go on to develop anterior pituitary dysfunction, 
including secondary hypogonadism (55). However, in 
our study traumatic brain injury was an exclusion cri-
terion. While limited data from patients with burns and 
critical illness have suggested a central, hypothalamic-
pituitary cause of trauma-related hypogonadism (56, 
57), the evidence prior to our study has been limited. 
Our data indicated a central cause of suppression to the 
gonadotrophic axis, with a decrease in both pituitary 
LH and gonadal testosterone. Interestingly, we observed 
a differential impact of the cumulative opioid dose on 
adrenal and gonadal androgens, respectively, with a sig-
nificantly delayed recovery of DHEA and DHEAS, but 
a trend towards faster recovery of gonadal testosterone 
synthesis in patients with higher cumulative opioid 
doses. Previous data on opioid effects on adrenal an-
drogen production are very scarce, but our findings with 
respect to gonadal testosterone biosynthesis contrasted 
previous studies describing suppressive opioid effects on 
the HPG axis (41, 42).
Our study revealed a loss of both adrenal and gonadal 
androgen production in young and middle-aged men 
after major trauma. This effect was further enhanced 
by long-lasting suppression of androgen-activating sys-
temic 5α-reductase activity, as demonstrated by urinary 
steroid metabolite analysis. Androgens are important in 
wound healing, erythrocytosis, bone density, and muscle 
mass (58). The catabolic state that occurs following 
trauma thus presents a significant challenge. The use 
of androgens to ameliorate catabolism has some prece-
dent, as evidenced by the use of the synthetic androgen, 
oxandrolone, that has some proven benefit in treating 
burn injuries (9). A  meta-analysis of 15 randomised 
controlled trials of 806 burn patients by Li et al, showed 
significant benefits (P  <  0.05) for using oxandrolone, 
including less net weight loss, lean body mass loss, ni-
trogen loss, donor-site healing time, and length of stay 
in the catabolic and rehabilitative phases (59). The use 
of oxandrolone in major trauma was investigated in 2 
intensive care studies but no benefit was demonstrated 
(60, 61).
The strengths of our study include its prospective 
nature, narrow age range of the patients, single gender, 
single site for recruitment and analysis, and detailed 
follow-up over 6  months as well as the measurement 
of circulating (and in a smaller cohort also excreted) 
steroid hormones by state-of-the-art mass spectrom-
etry assays. Analyzing a young to middle-aged pa-
tient cohort has also reduced the confounding effects 
of age-related comorbidities. Another strength is the 
unique opportunity our study offered for analysis of the 
opioid effects on endocrine recovery, facilitated by de-
tailed prospective, longitudinal phenotyping with dedi-
cated software.
Our study was limited by the diverse nature of major 
trauma patients in relation to injury pattern and the in-
volvement of military casualties. The timing and number 
of observations during our study was pragmatic and 
some statistical comparisons were made using modeled 
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data. While we measured total cortisol and cortisone 
by tandem mass spectrometry, we did not measure free 
cortisol or cortisol-binding globulin. We were only able 
to measure urinary steroid excretion in a subcohort of 
patients, as accurate and repeated collection of 24-hour 
urine proved very challenging under ICU conditions. 
The estimation of nitrogen excretion was pragmatic due 
to the diverse nature of the patients and we were not 
able to record nitrogen intake. Ultrasound estimation 
of muscle thickness was performed at 4 different body 
sites, but many individuals had limbs missing or exten-
sive wounds that prevented measurements. While im-
perfect, the longitudinal nature of these measurements 
allowed us to model these changes over time.
In conclusion, in this most detailed and first pro-
spective study of the steroid response to major trauma, 
we followed the patients from severe injury to 6 months 
of recovery, revealing pronounced and sustained de-
creases in adrenal and gonadal androgen biosynthesis. 
Recovery of androgen production in the severely injured 
patients was mirrored by a switch from catabolism to 
anabolism as reflected by recovery of muscle mass and 
a decrease in nitrogen loss. Adrenal and gonadal an-
drogens correlated with risk of sepsis. It is tempting to 
suggest that an anabolic intervention with androgens or 
androgen precursors could have a beneficial effect on 
health outcomes during recovery from major trauma. 
However, this will need to be investigated by future 
intervention studies.
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